A PYMNTS Company

US: ChemChina-Syngenta $43 billion deal approved by Security Panel

By  |  August 22, 2016

China’s global ambitions cleared a big hurdle after the US national-security regulator approved China National Chemical Corp.’s planned $43 billion takeover of Swiss seed giant Syngenta AG.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The decision in favor of China National Chemical, or ChemChina, comes amid growing opposition to Chinese investment from Europe to Australia. If completed, it would be China’s largest overseas acquisition to date.

    The industry had been watching for a decision from the Committee on Foreign Investment in the US, or CFIUS, a government body with the power to block deals it deems a threat to the nation’s security, because about a quarter of Syngenta’s sales come from North America.

    While analysts and Chinese industry officials hailed the decision as a major step forward for what would be a landmark Chinese takeover, the deal still faces potential roadblocks from regulators in the European Union.

    ChemChina’s deal for Syngenta is significant not only for its size, but also what it represents for China. Acquiring the Swiss seed and pesticide giant’s intellectual property would be hugely valuable for China as it seeks to feed a growing middle class and modernize its sprawling agricultural industry.

    Full Content: NY Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.